Sunday - November 15, 2026
PolyU develops Tumour Heterogeneity Index to precisely identify breast cancer patient drug response, achieving a 56% pathological complete response rate
October 29, 2026
HONG KONG, Oct. 29 -- The Hong Kong Polytechnic University issued the following news release:

* * *

PolyU develops Tumour Heterogeneity Index to precisely identify breast cancer patient drug response, achieving a 56% pathological complete response rate

*

Researchers at The Hong Kong Polytechnic University (PolyU) have successfully developed an innovative imaging biomarker, the Tumour Heterogeneity Index (THI), which enables non-invasive assessm . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products